by Alice Wigington | May 26, 2026 | Uncategorized
EVolution Therapeutics is delighted to announce that we have joined the 2026 Accelerate@Babraham cohort. Supporting early-stage life science innovation Accelerate@Babraham is one of the UK’s leading life science accelerators. It helps early-stage companies strengthen...
by Alice Wigington | Apr 8, 2026 | Uncategorized
We’re excited to share that we’ve secured a place in Innovators Club Cohort VI! The Innovators Club is a 10-week accelerator programme run by the Science Entrepreneur Club (SEC). Over the coming months, we’ll strengthen our foundations through sessions on IP...
by Alice Wigington | Nov 11, 2025 | Uncategorized
EVolution Therapeutics has submitted its second patent application, marking another important milestone in the development of its RNA-enabled nanoparticle therapeutics platform. The new filing builds on the company’s growing intellectual property portfolio and...
by Alice Wigington | Oct 1, 2025 | Uncategorized
EVolution Therapeutics was last week invited to pitch at SPARK Global in Berlin, where co-founder and CTO, Professor Andrew Devitt, had the honour of presenting the company’s vision for transforming the treatment of chronic inflammatory disease through RNA-enabled...
by James Gavin | Sep 9, 2025 | News&blogs, Uncategorized
EVolution Therapeutics is pleased to welcome PhD student Sasha Kieran for a three-month work experience placement as part of her MIBTP programme. During her time with the team, Sasha will support the development of our investor engagement strategy, helping to map and...
by admin | Mar 21, 2024 | Uncategorized
EVolution Therapeutics was delighted to have been invited to exhibit at Venturefest 2024. Joining an array of innovative start-ups, Dr James Gavin and Alice Wigington were present throughout the day to talk about the scientific foundation of Evolution Therapeutics’...
